Business Description

iNova Pharmaceuticals markets and sells a range of market leading and trusted non-prescription pharmacy products and prescription medicine in over 20 countries across Asia, Africa, Australasia. Although constantly on the lookout for new categories, we currently focus on the following therapeutic areas:

  • Weight management (eg Duromine)
  • Cough & Cold (eg Duro-Tuss, Rikodeine and Pholtex)
  • Throat (eg Difflam/Andolex)
  • Skincare (eg Dermaveen)
  • Lifestyle (eg Optimega, Reef, Invisible Zinc)

See our Products page for further information.

Our passionate and dedicated teams, in our core markets work closely with a network of excellent healthcare professionals and pharmacies to quickly bring our products into the hands of patients and customers.Our country based commercial teams are supported by ‘Corporate Centres of Excellence’ professionals, for example: marketing and innovation, regulatory, medical affairs, supply chain, finance, technology, pharmacovigilance and human resources.

History

iNova’s strong range of products originate from Riker Laboratories and 3M Pharmaceuticals. The business was first formed in November 2006 as the result of the purchase of 3M’s Asia Pacific and Africa pharmaceutical and OTC business.  In the years since then the business has more than doubled in size through a combination of organic growth, business development and acquisitions.

In October 2017 the iNova business was sold by Valeant Pharmaceuticals International to a company jointly owned by Pacific Equity Partners (PEP) and The Carlyle Group. This presents another exciting period for iNova with both private equity owners being committed to investing further in the business to:

  • support expansion into Asia, via a hub in Singapore, as well as other international regions
  • continue to grow its foundational business in South Africa and Australasia
  • acquire and license new products

iNova is constantly seeking innovative new prescription and consumer healthcare medicines through strong partnerships with our licensors, and Our Business Development team welcomes licensing and co-marketing proposals.

The way we work

Vision

iNova’s trusted brands improve people’s health and well-being everyday

Mission

To be a diversified A$1B+ healthcare company and partner of choice; delivering branded products & solutions to patients and consumers in Asia, Australasia and Africa

Purpose

  • Recognised by Healthcare professionals, their patients and consumers as a trusted expert and partner for their health and wellness needs
  • A dynamic and motivated team engaged to collectively achieve our full potential
  • Nimble, hungry and innovative in everything we do
  • Respected for delivering trusted, market leading, healthcare products and solutions through a high performing operating platform

Act ethically

Do the right thing …
everyday and
in everything we do

Act Ethically

Own it

Be involved:
see it, say it, do it

Own-it-icon

Embrace the pace

Decide fast, win fast,
fail fast, learn fast, fix fast

Embrace the pace icon
Customers Icon

Customers:
always front of mind

Really listen to and consider our HCP partners, their patients and consumers in everything we do

Do our best icon

Do our best

Be the best at what we do:
expert in our business, brands
and customers

Shift our thinking icon

Shift our thinking

Be bold and brave:
what could we do …
what will it take

Stronger together icon

Stronger
together

Internally: collaborate, share learnings, communicate, listen, leverage our diversity, assist others

Externally: seek contribution from & work closely with our customers, HCPs and suppliers